Fundz

Locus Biosciences, Inc. reported raising $12.5 Million in an initial SEC Form D filing, from an offering of $15 Million

PRIVATEJul 14, 2020$12.5M of $15M raised

Amount Raised

$12.5 Million

$12.5 Million sold, per SEC Form D (first sale Jul 14, 2020)

Round Type

Venture

Research Triangle ParkBiotechnology

Who to call at Locus Biosciences, and when

A new round usually means Locus Biosciences is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Locus Biosciences raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Locus Biosciences, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Locus Biosciences. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Locus Biosciences

Location

Research Triangle Park, North Carolina, United States

About

Next generation CRISPR technology for programmed cell death. Focused on developing therapies for infectious disease and the microbiome. Locus Biosciences’ novel approach to precision antimicrobials works by taking advantage of a part of an immune system present in many bacteria called the CRISPR-Cas system. The CRISPR-Cas system protects bacteria from invaders such as viruses by creating small strands of RNA called CRISPR RNAs, which match DNA sequences specific to a given invader. When the CRISPR RNAs find a match, they activate Cas proteins that cut the DNA.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Locus Biosciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts35 people are listed at Locus Biosciences. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Locus Biosciences's next move

See what Strategic adds

Locus Biosciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.